Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Second-line Switch to Dolutegravir Study (2SD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04229290
Recruitment Status : Not yet recruiting
First Posted : January 18, 2020
Last Update Posted : January 28, 2020
ViiV Healthcare
Information provided by (Responsible Party):
Loice Achieng, University of Nairobi

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : June 30, 2021
Estimated Study Completion Date : July 30, 2021